288 related articles for article (PubMed ID: 16258154)
1. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
[TBL] [Abstract][Full Text] [Related]
4. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
[TBL] [Abstract][Full Text] [Related]
6. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
[TBL] [Abstract][Full Text] [Related]
7. Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator.
Sahota SS; Babbage G; Zojer N; Ottensmeier CH; Stevenson FK
Methods Mol Med; 2005; 115():129-44. PubMed ID: 15998966
[TBL] [Abstract][Full Text] [Related]
8. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
9. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
[TBL] [Abstract][Full Text] [Related]
10. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of the forms of chronic lympholeukemia in relation to the mutational status of the genes of the immunoglobulin variable region].
Nikitin EA; Pivnik AV; Sudarikov AB; Valova GM; Gabeeva NG; Samoĭlova RS; Ivanov DV; Melikian AL; Kovaleva LG
Ter Arkh; 2000; 72(7):52-6. PubMed ID: 10983322
[TBL] [Abstract][Full Text] [Related]
12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region as a by-product of somatic hypermutation.
Bende RJ; Aarts WM; Pals ST; van Noesel CJ
Leukemia; 2002 Apr; 16(4):636-44. PubMed ID: 11960344
[TBL] [Abstract][Full Text] [Related]
14. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
[TBL] [Abstract][Full Text] [Related]
15. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA
J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317
[TBL] [Abstract][Full Text] [Related]
16. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.
Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S
Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098
[TBL] [Abstract][Full Text] [Related]
17. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R
Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062
[TBL] [Abstract][Full Text] [Related]
18. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
20. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.
Vasconcelos Y; Davi F; Levy V; Oppezzo P; Magnac C; Michel A; Yamamoto M; Pritsch O; Merle-Béral H; Maloum K; Ajchenbaum-Cymbalista F; Dighiero G
J Clin Oncol; 2003 Nov; 21(21):3928-32. PubMed ID: 14581416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
